P2.04-001 BALTIC: A Phase 2, Open-Label Study of Novel Combinations of Immunotherapies or DDR Inhibitors in Platinum-Refractory ED-SCLCI. Vynnychenko,H. Jiang,Y. Huang,P. Dennis,J. Von PawelJournal of Thoracic Oncology（2017）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
